B. JAIN PHARMACEUTICALS PRIVATE LIMITED – FDA Inspection, Aug 29, 2018

Record Details

This FDA Inspection record concerns B. JAIN PHARMACEUTICALS PRIVATE LIMITED, with an inspection on August 29, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: B. JAIN PHARMACEUTICALS PRIVATE LIMITED
Inspection Date: August 29, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research
People: Kellia N. Hicks (FDA Associated Person)
Marvin D. Jones (FDA Associated Person)

View Company Profile

ID · d8116f9c-d917-4ae0-ba64-a903bba13b82

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1069363
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore B. JAIN PHARMACEUTICALS PRIVATE LIMITED

FDA Inspection

B. JAIN PHARMACEUTICALS PRIVATE LIMITEDAugust 29, 2018